[Effect of levamisole immunocorrective therapy on the dynamics of infectious O-antigenemia and the clinical manifestations in dysentery patients].
The immunocorrecting agent levamisole decreases the duration of infectious O-antigenemia, determined in the O-aggregate hemagglutination test and in the enzyme immunoassay, essentially accelerates the progress of convalescence and considerably decreases the possibility of the prolonged relapsing course of the disease in comparison with common methods of treatment.
N V
NV
Kravchenko
I V
IV
Rubtsov
A V
AV
Tregub
D000293:Adolescent; D000328:Adult; D000942:Antigens, Bacterial / Q000032:analysis*; D004341:Drug Evaluation; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000276:immunology; D006386:Hemagglutination Tests; D006801:Humans; D007124:Immunoenzyme Techniques; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D019081:O Antigens; D012008:Recurrence; D012763:Shigella flexneri / Q000276:immunology; D012764:Shigella sonnei / Q000276:immunology
D000942:Antigens, Bacterial; D019081:O Antigens; D007978:Levamisole
Vliianie immunokorrigiruiushcheĭ terapii levamizolom na dinamiku infektsionnoĭ O-antigenemii i klinicheskie proiavleniia u bol'nykh dizenterieĭ.